OrganOx Ltd, a world-leading organ medical technology company, today announced Health Canada has approved the OrganOx metra ® System for use during liver transplantation. The OrganOx metra ® System is ...

Conformal Medical, Inc. today announced the initiation of the GLACE Study. This European study* aims to assess the use of intracardiac echocardiography (ICE) imaging of the left atrial appendage (LAA) ...

The biopharma industry is at the forefront of medical innovation, driven by the groundbreaking work of leading scientists. These individuals are not only advancing our understanding of complex ...

Philips helps healthcare organizations worldwide assess and mitigate their environmental impact while enabling better care and better care outcomes for more patients at lower cost “Good healthcare has ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today ...

When it comes to personal health, many issues command immediate attention. A cough, fever, or injury are clear signs that something might be wrong. However, some conditions, like nail fungus, often go ...

Patient engagement platforms are changing how healthcare is delivered by improving communication and handling administrative tasks. These platforms can send appointment reminders, procedure ...

As we strive for better health and wellness, natural remedies have become a popular option. While medical science and technology have made it easier to treat various conditions, many people are ...

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series ...

Celaid Therapeutics Inc. announced today that it has been awarded up to approx. 2.7 billion yen ($19M USD) in non-dilutive grant funding as “Strengthening Program for Pharmaceutical Startup Ecosystem” ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced late-breaking data from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast Reduction) trial, the ...